Beckman Coulter Files a 510(k) Submission with the FDA for its Early Sepsis Indicator
Offered as part of a routine CBC with differential test, the hematology-based solution is intended to alert emergency department clinicians to sepsis or the possibility of sepsis earlier than any other indicator